Halobetasol propionate and tazarotene


Generic Name:
Halobetasol propionate and tazarotene
Project Status:
Therapeutic Area:
Psoriasis, moderate to severe plaque
Bausch Health, Canada Inc.
Call for patient/clinician input open:
Brand Name:
Project Line:
Reimbursement Review
Project Number:
Call for patient/clinician input closed:
NOC Status at Filing:
Manufacturer Requested Reimbursement Criteria1:
Improving the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.
Submission Type:
Fee Schedule:
Schedule A
Improving the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Key Milestones2

Call for patient input open December 19, 2019
Call for patient input closed February 14, 2020

- Patient input submission received from Canadian Psoriasis Network (CPN), Canadian Skin Patient Alliance (CSPA) and the Canadian Association of Psoriasis Patients (CAPP)

Submission received January 24, 2020
Submission accepted February 07, 2020
Review initiated February 10, 2020
Draft CADTH review report(s) provided to sponsor for comment April 24, 2020
Deadline for sponsors comments May 05, 2020
CADTH responses on draft review report(s) provided to sponsor June 05, 2020
Expert committee meeting (initial) June 17, 2020
Draft recommendation issued to sponsor June 30, 2020
End of embargo period August 13, 2020

- Request for extension to embargo period received from the sponsor

- Embargo extension request granted

- Reconsideration requested

Expert committee meeting October 21, 2020
Final recommendation issued to sponsor and drug plans October 28, 2020
Final recommendation posted October 30, 2020
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) November 11, 2020
CADTH review report(s) posted December 17, 2020